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Abstract
Background: In view of the role of TLR2 activation in host defense against mycobacteria, the
present study was conducted to examine whether TLR2 polymorphisms could account for the
increased prevalence of tuberculosis in Indian patients. Detection of such polymorphisms would
help in assessing the risk of developing active tuberculosis among contacts or HIV positive patients
and in identifying candidates for chemoprophylaxis.
Findings: One hundred patients with tuberculosis and 100 controls were investigated for the
presence of two TLR2 polymorphisms, viz. Arg753Gln and Arg677Trp, using PCR-RFLP of a 340
bp region of the TLR2 gene, followed by DNA sequencing of a randomly selected group of 35
patients. While these polymorphisms were found to be non-existent in our study groups, we
observed a novel polymorphism Phe749Tyr in 2 patients. However, this polymorphism was
associated with negligible deviation in Delphi electrostatic potential and structural alignment from
the wild-type TLR2 protein, making it an unlikely candidate for any significant structural or
functional alteration at the protein level.
Conclusion: Hence we conclude that, contrary to reported associations in other populations,
TLR2 polymorphisms are not responsible for the increased prevalence of TB in the Indian
population.
Research hypothesis
Of the different members of the Toll-like receptor (TLR)
family, TLR2 has been shown to be a principal mediator
of macrophage activation in response to mycobacteria.
Defective TLR2 genes have been associated with sup-
pressed macrophage response to mycobacteria in both
animal and human studies. Expression of mutant TLR2
(Pro681His) in RAW murine macrophages inhibited
TNFα production in response to both virulent and aviru-
lent mycobacteria [1]. Comparing the resistance to air-
borne infection with M. tuberculosis in TLR2, TLR4, CD14
knockout and control mice groups, Reiling et al found
that TLR2 knockout mice showed decreased resistance to
TB on high-dose exposure [2]. In addition, two single
nucleotide polymorphisms (SNPs) (Arg677Trp and
Arg753Gln) of the TLR2 gene have been identified by
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Bochud et al that impaired the macrophage response to
M. leprae and M. tuberculosis in humans [3]. While the
Arg677Trp polymorphism was found to associate with TB
in a Tunisian population [4] and with lepromatous lep-
rosy in a Korean population [5], it was not detected
among Caucasians [6]. The other SNP, Arg753Gln, was
shown to significantly correlate with tuberculosis in a
Turkish population; thereby signifying that polymor-
phism in the TLR2 gene demonstrated an ethnic variation
[7].
Considering the fact that India is home to a third of the
global cases of tuberculosis, we hypothesized that these
SNPs in the TLR2 gene could contribute to the high bur-
den of TB among Indian patients. Detection of such poly-
morphisms in tubercular patients would help in assessing
the risk of developing active TB among contacts or HIV
positive patients and in identifying candidates for chemo-
prophylaxis.
Methods
One hundred patients suffering from Pulmonary TB were
recruited from the Community Health Clinics and OPDs
of Himalayan Institute of Medical Sciences, Dehradun,
India. The diagnosis of Pulmonary TB in these patients
was confirmed by sputum-smear microscopy done on
three consecutive sputum samples. The control group
included 60 healthy household contacts of the recruited
cases and 40 healthy individuals without any past history
of TB. The study design was approved by the institutional
ethics committee, in concordance with national guide-
lines. After obtaining written informed consent, blood
samples were collected from the patients and controls in
EDTA vials and their clinical details were recorded.
Genomic DNA was extracted from the blood samples,
using QIAamp DNA Blood Minikit (Qiagen).
To detect the TLR2 polymorphism, a 340 bp region of the
TLR2 gene was amplified, as previously reported [6] using
the following primers: forward 5'-GCCTACTGGGTGGA-
GAACCT-3' & reverse 5'-GGCCACTCCAGGTAGGTCTT-
3'. Approximately 40 ng sample DNA was added to a reac-
tion volume of 25 μl containing 2.5 μl 10× buffer, 2 mM
MgCl2, 0.2 μl deoxyribonucleoside triphosphate mix and
25 pmol of each primer. PCR was performed under the
following conditions: 95°C for 10 mins, followed by 30
cycles of 95°C for 30 secs, 58°C for 30 secs, and 72°C for
25 secs, and a final elongation step of 72°C for 5 mins.
Following PCR, 3 μl of the amplicon was incubated for 2
hours with 0.5 U AciI in a total volume of 10 μl at 36°C.
Samples were subjected to agarose gel electrophoresis to
identify digestion patterns characteristic of wild-type and
mutant TLR2.
To confirm the results of PCR-RFLP, DNA sequencing of
the amplicons was performed on a randomly selected
group of 35 patients at the Deptt. of Biochemistry, Univer-
sity of Delhi, India.
To sense the SNPs in the selected DNA sequences, multi-
ple sequence alignment was performed using built in
interface for ClustalW [8] in Genchek software version
2.4.1.5 from Ocimum Biosolutions. The gap opening, gap
extension penalty were set to 15 and 6.66 respectively.
DNA Identity scoring matrix was used for the alignment.
To validate the result at protein level, all aligned
sequences along with the gaps were translated to protein.
Protein sequence of TLR2 gene (Accession no.
NP_003255.2) was downloaded from the NCBI server [9].
TIR domain of TLR2 (Amino acid 639: 784) was analyzed
for its structural detail. Homology modeling approach
was followed to design the 3D structure of TIR domain
using 1FYX|A and 1FYV|A with 'Build homology model'
protocol based on modeler interface [10] available on
Discovery studio. Mutant model was developed for the
modeled structure of TIR domain by using 'Build mutants'
protocol for the observed mutation (F749Y) in few sam-
ples. Both structures were analyzed for changes in electro-
static potential using Delphi [11] on Discovery studio.
The program calculates the electrostatic properties for
molecular system using a finite difference solution to the
nonlinear Poisson-Boltzmann equation [12]. In Delphi
analysis, one quantity that is often important is the
change in pK at some location due to a site-directed muta-
tion at another location. Change in pK due to change in
amino acid group was calculated as eq (1).
φ0 = the potential at site i due to the original group
φm = the potential at site i due to the mutated group
γi = -1 or 1 for an acidic or basic group, respectively.
To solve the problem of change in pK, two DelPhi calcu-
lations were carried out, one for the original molecule to
find φ0, and another to find φm. In both calculations, the
only charges present in the molecule are those on the
group involved in the mutation. Since all of the other
charges in the molecule are the same in both cases, the
contribution to the potential at the site of interest due to
these charges is also the same and, therefore, does not
have to be included. Further, 3D structure of TIR and
mutated model were superimposed to analyze any struc-
tural difference because of polymorphism found in some
samples.
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Results
One hundred patients with TB and 100 controls (includ-
ing 60 healthy household contacts of TB patients and 40
unrelated healthy volunteers) were investigated for the
presence of the two TLR2 polymorphisms. The demo-
graphic and clinical characteristics of the study groups are
summarized in Table 1.
Screening for the presence of the two polymorphisms was
done using PCR amplification of a 340 bp region of the
TLR2 gene, followed by RFLP with AciI enzyme. While
wild-type TLR2, on restriction digestion, yielded a frag-
ment of 227 bp, Arg753Gln and Arg677Trp polymor-
phisms were associated with fragments measuring 265 bp
and 302 bp respectively. Among the patients, we did not
find any of the polymorphisms in heterozygote or
homozygote form. Similarly, none of the polymorphisms
could be detected among the household contacts or the
healthy controls (Table 2).
To confirm the absence of the two polymorphisms,
Arg677Trp and Arg753Gln in our patients, we undertook
DNA sequencing of the PCR amplicons derived from 35
randomly selected patients, covering the region 2029 to
2258. We performed multiple alignment of PCR ampli-
cons with TLR2 mRNA (NCBI accession no.
NM_003264.3). We found the DNA sequences to be
highly conserved among the patients (Figure 1).
Entire multiple aligned sequences translated along with
the gaps to analyze the result at protein level. In our
patients, we found that position nos. 677 and 753 (figure
2) are conserved, confirming the absence of two polymor-
phisms (Arg677Trp, Arg753Gln). However, we found one
polymorphism Phe749Tyr in two of the randomly
selected samples (S37, S43), which was further analyzed
with the help of bioinformatics tools.
3D structure of TIR domain designed using homology
modeling approach by using engineered mutated toll like
receptor 2 chain A (1FYX) and toll like receptor 1 chain A
(1FYV) of Homo sapiens available with protein data bank
[13]. Electrostatic potential of the model was evaluated
using Delphi electrostatic calculation. Charges on individ-
ual atom in the model for Delphi calculation were taken
from Charmm22 force field charge and atomic radii were
taken from the Bondi radii set [14]. Same calculation was
repeated for the mutated model (Phe749Tyr) designed
through 'Build Mutant' protocol of Discovery studio.
Total grid energy of TIR model, mutated model as calcu-
lated by Delphi was 1754.014 kt and 1789.582 kt respec-
tively. Total grid energy is the sum of the products of
electrostatic potential at each grid point and the grid
charges. It is calculated as the interactions of molecular
charges with their own induced potential. Thus, only the
differences of total grid energies for two Delphi runs are
meaningful. The difference here was only 35.568 kt. Also,
the difference in the coulombic energy (the energy of
intramolecular electrostatic interactions in a uniform
medium with the properties of the solute) was found to be
61.7 kt only. The difference in total reaction field energy
(the transfer energy of a solute from a medium with the
dielectric properties of the molecule to the solution) of
two models was 7.98 kt only. Comparative results of Del-
phi calculations are summarized in Table 3. To analyze
changes because of Phe749Tyr polymorphism at structure
level, both the models were superimposed by using 'Align
Structure' protocol on Discovery studio (figure 3). The
overall RMSD calculated between two structures based on
all 146 residues were 0.20 Angstrom only.
Discussion
In this study we observe that, contrary to reported associ-
ations with mycobacterial diseases in other populations
[4,5,7], TLR2 polymorphisms are not responsible for the
increased prevalence of TB in the Indian population. We
also report for the first time the presence of a novel poly-
morphism in the TLR2 gene, viz. Phe749Tyr. In-silico
analysis, however, showed this to be an unlikely candi-
date for any significant structural or functional alteration
at the protein level. There is no data regarding TLR2 poly-
Table 1: Demographic and clinical characteristics of the recruited subjects
Patients Controls
No. of subjects 100 100
Age (yrs): (Mean ± SD) 42.52 ± 20.94 35.78 ± 16.56
Male/Female 64/36 72/28
Past h/o TB 7 0
Family h/o TB (other than index case) 6 3
Duration of illness (months): (Mean ± SD) 19.2 ± 3.5
Pulmonary TB 80
< 3 lobes involved (%) 52 (65)
≥ 3 lobes involved (%) 28 (35)
Extra-pulmonary TB 20BMC Research Notes 2009, 2:162 http://www.biomedcentral.com/1756-0500/2/162
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morphisms in people from the Indian subcontinent till
date. Hence, our data could provide useful information
on the Indian population for studies aimed at exploring
the putative relevance of TLR2 SNPs not only in TB, but
also in a range of other infectious and inflammatory dis-
eases, in which the roles of TLR2 have been incriminated.
A number of previous studies have explored the occur-
rence of TLR2 polymorphisms in various diseased and
healthy populations. The findings of these studies reveal
marked variability depending on the ethnicity of the pop-
ulation scanned. While the Arg753Gln SNP has been
reported exclusively in the Caucasian population, the
Arg677Trp polymorphism has been observed in Asian
and African populations. The most remarkable associa-
tion with mycobacterial diseases was observed for the
Arg677Trp polymorphism, which was detected in 22% of
lepromatous leprosy patients in a Korean population,
while being absent in patients of tuberculoid leprosy and
healthy controls [5]. This polymorphism was also found
to associate with TB in a Tunisian population, where the
mutation was observed in 94% of 34 patients compared
to 31% of 34 healthy controls [4]. Contrary to the study
conducted by Kang et al [5], other authors have failed to
detect these TLR2 polymorphisms in the Korean popula-
tion. Examining the prevalence of TLR2 and TLR4 SNPs in
bacteremic patients from Korea, Yoon et al observed no
genetic polymorphism in patients or healthy controls,
suggesting these SNPs to be extremely rare in this popula-
tion [15]. Similarly, Ryu et al observed that TLR2 poly-
morphisms did not appear to be responsible for host
susceptibility to lung diseases caused by non-tubercular
mycobacteria in the Korean population [16]. In the Cau-
casian population, the Arg753Gln SNP was detected in
9.4% of the German whites, while the Arg677Trp poly-
morphism was not observed at all [6]. In separate studies,
the Arg753Gln allele was observed among 10.34% [17]
and 12.3% [18] of healthy Turkish subjects, while the
Arg677Trp was not observed. Lorenz et al identified the
Arg753Gln polymorphism among almost 3% of recruited
subjects in another Caucasian population and speculated
that the mutation could be a risk factor for developing
septic shock after infection by gram-positive bacteria [19].
The absence of the TLR2 SNPs in the present study, which
concurs with most of the Korean studies [15,16] and is in
contrast to studies in Caucasian or African populations,
could mirror the ethnic relatedness of the populations
being compared.
Conclusion
Therefore, based on our observations, it may be con-
cluded that variations of the TLR2 genotype are not
Table 2: Genotype distribution of TLR2 polymorphisms in 
recruited subjects
Genotype Patients
(n = 100)
Controls
(n = 100)
TLR2 Arg753Gln
-/- 100 100
+/- - -
+/+ - -
TLR2 Arg677Trp
-/- 100 100
+/- - -
+/+ - -
Highly conserved multiple aligned sequences of a representative group of 12 patients along with TLR2 mRNA (NCBI accession  no. NM_003264.3) Figure 1
Highly conserved multiple aligned sequences of a representative group of 12 patients along with TLR2 mRNA 
(NCBI accession no. NM_003264.3). Region of interest, for SNP detection were enclosed in Black rectangle showing 
absence of desired SNPs (G/A, C/T at position 2030 & 2257 respectively) in our samples. Further new SNP (T/A) detected in 2 
samples at position 2246 (marked with red arrow).
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Translated multiple alignment sequences along with gaps Figure 2
Translated multiple alignment sequences along with gaps. Positions 677 and 753 marked with red arrow showing 
highly conserved ARG. In two samples (S43, S37) amino acid PHE at position 749 mutated to TYR (Black arrow)
 
Table 3: Comparison of Delphi electrostatic potential calculation for TIR model and mutated model (PHE749TYR)
TIR model Mutated model of TIR(PHE749TYR)
Total grid energy 1754.014 kt 1789.582 kt
Corrected reaction field energy -2123.505 kt -2084.618 kt
Total reaction field energy -24231.67 kt -24239.65 kt
Coulombic energy -31277.80 kt -31339.50 kt
All calculation was performed with 33 Grid Points per Axis and Grid Filled By Solute parameter as 80%.
1 kT = 0.592 kcal/mol
Superimposed model of TIR domain of human TLR2 (Green) with mutated model (Red) Figure 3
Superimposed model of TIR domain of human TLR2 (Green) with mutated model (Red). Position 749 showing 
non-significant structural difference because of Phe749Tyr
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responsible for the increased susceptibility to TB in the
Indian population. This calls for further studies to identify
potential genetic factors, which might explain the
increased burden of TB in our patients. Other population
groups within the ethnically diverse Indian population
also need to be recruited to understand the impact of
these polymorphisms towards the development of TB in
the Indian subcontinent.
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